Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-Year results of a randomized clinical trial - VIP report no. 3

Kevin J. Blinder, Mark S. Blumenkranz, Neil M. Bressler, Susan B. Bressler, Guy Donati, Hilel Lewis, Jennifer I. Lim, Ugo Menchini, Joan W. Miller, Jordi M. Mones, Michael J. Potter, Constantin Pournaras, Al Reaves, Philip Rosenfeld, Andrew P. Schachat, Ursula Schmidt-Erfurth, Michel Sickenberg, Lawrence J. Singerman, Jason S. Slakter, H. Andrew StrongGianni Virgili, George A. Williams

Research output: Contribution to journalArticlepeer-review

336 Scopus citations

Fingerprint Dive into the research topics of 'Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-Year results of a randomized clinical trial - VIP report no. 3'. Together they form a unique fingerprint.

Medicine & Life Sciences